TCTC Holdings’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,250
| Closed | -$39K | – | 549 |
|
|
2025
Q4 | $39K | Hold |
1,250
| – | – | ﹤0.01% | 375 |
|
|
2025
Q3 | $25.3K | Hold |
1,250
| – | – | ﹤0.01% | 415 |
|
|
2025
Q2 | $20.9K | Hold |
1,250
| – | – | ﹤0.01% | 457 |
|
|
2025
Q1 | $19.2K | Hold |
1,250
| – | – | ﹤0.01% | 477 |
|
|
2024
Q4 | $27.6K | Hold |
1,250
| – | – | ﹤0.01% | 390 |
|
|
2024
Q3 | $22.5K | Hold |
1,250
| – | – | ﹤0.01% | 390 |
|
|
2024
Q2 | $20.3K | Sell |
1,250
-625
| -33% | -$9.63K | ﹤0.01% | 401 |
|
|
2024
Q1 | $26.5K | Hold |
1,875
| – | – | ﹤0.01% | 367 |
|
|
2023
Q4 | $19.6K | Hold |
1,875
| – | – | ﹤0.01% | 379 |
|
|
2023
Q3 | $19.1K | Hold |
1,875
| – | – | ﹤0.01% | 327 |
|
|
2023
Q2 | $14.1K | Sell |
1,875
-600
| -24% | -$4.87K | ﹤0.01% | 342 |
|
|
2023
Q1 | $21.9K | Hold |
2,475
| – | – | ﹤0.01% | 339 |
|
|
2022
Q4 | $22.6K | Hold |
2,475
| – | – | ﹤0.01% | 325 |
|
|
2022
Q3 | $20K | Hold |
2,475
| – | – | ﹤0.01% | 316 |
|
|
2022
Q2 | $19K | Hold |
2,475
| – | – | ﹤0.01% | 324 |
|
|
2022
Q1 | $23K | Sell |
2,475
-450
| -15% | -$3.75K | ﹤0.01% | 321 |
|
|
2021
Q4 | $23K | Sell |
2,925
-2,800
| -49% | -$25.3K | ﹤0.01% | 352 |
|
|
2021
Q3 | $56K | Sell |
5,725
-2,176
| -28% | -$20.4K | ﹤0.01% | 294 |
|
|
2021
Q2 | $78K | Sell |
7,901
-4,041
| -34% | -$42.8K | ﹤0.01% | 245 |
|
|
2021
Q1 | $138K | Sell |
11,942
-900
| -7% | -$10.3K | 0.01% | 196 |
|
|
2020
Q4 | $124K | Sell |
12,842
-439
| -3% | -$4.21K | 0.01% | 194 |
|
|
2020
Q3 | $120K | Sell |
13,281
-1,100
| -8% | -$11.6K | 0.01% | 192 |
|
|
2020
Q2 | $177K | Buy |
+14,381
| New | +$163K | 0.01% | 165 |
|
|
2017
Q2 | – | Sell |
-153,198
| Closed | -$4.92M | – | 179 |
|
|
2017
Q1 | $4.92M | Buy |
153,198
+30,974
| +25% | +$1.06M | 0.3% | 65 |
|
|
2016
Q4 | $4.43M | Buy |
+122,224
| New | +$4.88M | 0.27% | 65 |
|
|
2016
Q3 | – | Sell |
-129,706
| Closed | -$6.51M | – | 178 |
|
|
2016
Q2 | $6.51M | Sell |
129,706
-600
| -0.5% | -$31.9K | 0.44% | 51 |
|
|
2016
Q1 | $6.97M | Sell |
130,306
-12,900
| -9% | -$757K | 0.44% | 48 |
|
|
2015
Q4 | $9.4M | Sell |
143,206
-800
| -0.6% | -$49.4K | 0.56% | 38 |
|
|
2015
Q3 | $8.13M | Sell |
144,006
-6,223
| -4% | -$403K | 0.46% | 42 |
|
|
2015
Q2 | $8.88M | Buy |
150,229
+9,225
| +7% | +$569K | 0.51% | 42 |
|
|
2015
Q1 | $8.78M | Sell |
141,004
-7,350
| -5% | -$427K | 0.52% | 43 |
|
|
2014
Q4 | $8.53M | Sell |
148,354
-12,200
| -8% | -$680K | 0.52% | 43 |
|
|
2014
Q3 | $8.63M | Buy |
+160,554
| New | +$8.51M | 0.5% | 42 |
|
|
2014
Q2 | – | Sell |
-161,700
| Closed | -$8.54M | – | 170 |
|
|
2014
Q1 | $8.54M | Sell |
161,700
-35,167
| -18% | -$1.63M | 0.49% | 40 |
|
|
2013
Q4 | $7.89M | Buy |
196,867
+23,731
| +14% | +$934K | 0.45% | 41 |
|
|
2013
Q3 | $6.54M | Sell |
173,136
-14,001
| -7% | -$546K | 0.42% | 46 |
|
|
2013
Q2 | $7.34M | Buy |
+187,137
| New | +$7.29M | 0.48% | 41 |
|
Other funds holding TEVA
HIIFS
PF
MMH
CI
MIFH
LIM
TCTC Holdings's TEVA Position: Q1 2026 in Review
TCTC Holdings sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 1,250 shares — an estimated $39K sold.
TCTC Holdings first reported a position in TEVA in Q2 2013 and held it in 37 quarters. The position peaked at $9.4M in Q4 2015. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.
- TCTC Holdings reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- TCTC Holdings sold 1,250 Teva Pharmaceuticals shares in Q1 2026, an estimated $39K.
- TCTC Holdings first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 37 quarters.
- TCTC Holdings's Teva Pharmaceuticals position peaked at $9.4M in Q4 2015.
- 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.
Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.